Skip to main content

Peters William J's Form 4 filing

Amphastar Pharmaceuticals, Inc. (AMPH) · filed Nov 16, 2023

Accession no.
0001104659-23-119090
Filed
Nov 16, 2023
Trade date
Nov 14, 2023
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.30M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Peters William JCIK 0001263136Director, Officer (CFO, EVP & Treasurer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 14, 2023Common StockMOption exerciseAcquired+21,250$20.23+$429,887.5122,610Direct
Nov 14, 2023Common StockMOption exerciseAcquired+38,000$13.03+$495,140160,610Direct
Nov 14, 2023Common StockSSaleDisposed−14,220$54.76−$778,687.2146,390Direct
Nov 14, 2023Common StockSSaleDisposed−30,162$55.67−$1,679,118.54116,228Direct
Nov 14, 2023Common StockSSaleDisposed−14,868$56.53−$840,488.04101,360Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 14, 2023Common StockMOption exerciseDisposed−21,250$0.00$015,225Direct
Nov 14, 2023Common StockMOption exerciseDisposed−38,000$0.00$031,100Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)